Clinical Impact of New HIV Data From the 2016 Co-morbidities and Adverse Drug Reactions Workshop

September 12-13, 2016; New York, New York
In this Expert Analysis, Todd T. Brown, MD, PhD, and Jordan E. Lake, MD, MSc, provide an in-depth discussion of the most clinically relevant new data on the management of patients with HIV infection presented at the Co-morbidities and Adverse Drug Reactions workshop in New York, New York.
Todd T. Brown, MD, PhD
Jordan E. Lake, MD, MSc
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Released: December 16, 2016 Expiration: December 15, 2017

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply data from studies of antiretroviral agents used to prevent HIV infection
  • Devise management strategies based on the results of recent clinical studies of antiretroviral agents in treatment-naive and treatment-experienced patients
  • Integrate best practices for the management of adverse events associated with HIV, antiretroviral therapy, and comorbidities

Acknowledgements

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grant provided by:
Bristol-Myers Squibb

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Todd T. Brown, MD, PhD

Professor of Medicine and Epidemiology
Division of Endocrinology, Diabetes and Metabolism
Johns Hopkins University
Baltimore, Maryland

Todd T. Brown, MD, PhD, has disclosed that he has received consulting fees from Bristol-Myers Squibb, EMD Serono, Gilead Sciences, Merck, and Theratechnologies.
Jordan E. Lake, MD, MSc

Associate Professor
Division of Infectious Diseases
McGovern School of Medicine
University of Texas Health Science Center at Houston
Houston, Texas

Jordan E. Lake, MD, MSc, has disclosed that she has received consulting fees from Gilead Sciences and GlaxoSmithKline.

Staff

Rachael M. Andrie, PhD

Clinical Editor

Rachael M. Andrie, PhD, has no real or apparent conflicts of interest to report.
Jennifer M. Blanchette, PhD

Managing Editor

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no real or apparent conflicts of interest to report.
Jenny Schulz, PhD

Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
Carolyn Skowronski, PharmD

Managing Editor

Carolyn Skowronski, PharmD, has no real or apparent conflicts of interest to report.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education, Debbie Price, Database Administrative Secretary, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the care of patients at risk of or infected with HIV.

Goal

The goal of this activity is to improve participants’ competence in translating the most clinically significant data from an important scientific meeting into practical management strategies for individuals at risk of or infected with HIV.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 16, 2016, through December 15, 2017:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.

Related Content

Watch an HIV expert panel discuss managing HCV infection in MSM, prescribing HIV PrEP to a PWID, and managing CVD in an HIV-infected woman.

W. David Hardy, MD
Program Director
Princy N. Kumar, MD person default Jaimie P. Meyer, MD, MS, FACP Babafemi Taiwo, MBBS
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 18, 2018 Expiration: June 17, 2019

CME-certified expert panel discussion on initiating or switching ART in a series of challenging patient cases.

Monica Gandhi, MD, MPH
Program Director
Eric S. Daar, MD Sally Hodder, MD Babafemi Taiwo, MBBS
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.13 CEUs) Released: June 15, 2018 Expiration: June 14, 2019

Full slides: controversies in PrEP, ART initiation, and HIV treatment choices. From David A. Wohl, MD, Joseph J. Eron, Jr., MD, Princy N. Kumar, MD.

Released: May 29, 2018

In this downloadable slideset, Frederick L. Altice, MD, reviews the HIV treater’s role at the intersection of HIV infection, HCV infection, and the opioid crisis.

Released: April 26, 2018

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?